1.上海中医药大学附属曙光医院肝病科(上海 201203)
朱晓骏,女,博士,副主任医师,主要从事中西医结合治疗慢性乙型肝炎临床与基础研究
高月求,主任医师,教授;E-mail:gaoyueqiu0418@163.com
扫 描 看 全 文
朱晓骏,郑超,张鑫等.基于TLR3补肾健脾方水提物抑制乙肝病毒复制机制研究[J].上海中医药大学学报,2022,36(S1):149-153.
ZHU Xiaojun,ZHENG Chao,ZHANG Xin,et al.Mechanism study on inhibition of hepatitis B virus replication by TLR3 based water extract of Bushen Jianpi Decoction[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2022,36(S1):149-153.
朱晓骏,郑超,张鑫等.基于TLR3补肾健脾方水提物抑制乙肝病毒复制机制研究[J].上海中医药大学学报,2022,36(S1):149-153. DOI: 10.16306/j.1008-861x.2022.S1.035.
ZHU Xiaojun,ZHENG Chao,ZHANG Xin,et al.Mechanism study on inhibition of hepatitis B virus replication by TLR3 based water extract of Bushen Jianpi Decoction[J].Academic Journal of Shanghai University of Traditional Chinese Medicine,2022,36(S1):149-153. DOI: 10.16306/j.1008-861x.2022.S1.035.
目的,2,通过 pHBV1.3-pCR2.1质粒转染HepG2细胞探讨补肾健脾方水提物抑制乙肝病毒的免疫机制。,方法,2,250 μg/ml、500 μg/ml补肾健脾方水提物干预 pHBV1.3-pCR2.1质粒转染HepG2细胞,ELISA法检测细胞上清HBsAg、HBeAg含量;500 μg/ml补肾健脾方水提物干预pHBV1.3-pCR2.1质粒转染HepG2细胞,Westen blot法检测Toll样受体3(TLR3)、p-IRF3蛋白表达,qRT-PCR法检测细胞内,IFN,-,β, mRNA表达 ;补肾健脾方干预HepG2细胞,pHBV1.3-pCR2.1质粒转染HepG2细胞,TLR13 siRNA下调TLR3表达,Westen blot法检测TLR3、p-IRF3蛋白表达,qRT-PCR法检测细胞内,IFN,-,β, mRNA 表达。,结果,2,500 μg/ml补肾健脾方与空白对照组、250 μg/ml补肾健脾方比较,HBsAg均明显下降(,P<,0.05,,P<,0.01) ;500 μg/ml补肾健脾方与空白对照组、250 μg/ml补肾健脾方比较,HBeAg均明显下降(,P<,0.05,,P<,0.01);补肾健脾方(500 μg/ml)可以增强TLR3、p-IRF3蛋白表达,促进细胞内,IFN,-,β, mRNA 表达(,P,<,0.01);补肾健脾方干预 pHBV1.3-pCR2.1质粒转染HepG2细胞,TLR3 siRNA抑制细胞TLR3蛋白表达,p-IRF3蛋白表达明显下降,同时细胞内,IFN,-,β, mRNA 表达也明显下降(,P<,0.01)。,结论,2,补肾健脾方水提物通过增强 pHBV1.3-pCR2.1质粒转染HepG2细胞TLR3作用,促进细胞内IFN-β分泌,从而抑制乙型肝炎病毒的复制。
Objective: To explore the immune mechanism on the water extract of Bushen Jianpi Decoction in inhibiting hepatitis B virus in HepG2 cells transfected with plasmid pHBV1.3-pCR2.1.,Methods,2,After the water extract of Bushen Jianpi Decoction intervened in HepG2 cells transfected with plasmid pHBV1.3-pCR2.1 in two different concentrations(250 μg/ml and 500 μg/ml), HBsAg and HBeAg contents in cell supernatant were detected by ELISA. After the water extract of Bushen Jianpi Decoction intervened in HepG2 cells transfected with plasmid pHBV1.3-pCR2.1 in concentrations of 500 μg/ml, the expressions of TRL3, p-IRF3 protein were detected by WB, and the expression of ,IFN,-,β, mRNA was detected by qRT-PCR. Bushen Jianpi Decoction intervened in HepG2 cells led that HepG2 cells were transfected with plasmid pHBV1.3-pCR2.1 and TLR3 siRNA down regulated the expression of TLR3. The expressions of TLR3 and p-IRF3 protein were detected by Western blot, and the expression of ,IFN,-,β, mRNA was detected by qRT-PCR.,Results,2,HBsAg of Bushen Jianpi Decoction(500 μg/ml)was significantly decreased compared with that in Bushen Jianpi Decoction(250 μg/ml)and the model group(,P<,0.05,,P<,0.01). HBeAg of Bushen Jianpi Decoction(500 μg/ml)was significantly decreased compared with that in Bushen Jianpi Decoction(250 μg/ml)and the model group(,P<,0.05,,P<,0.01). Bushen Jianpi Decoction(500 μg/ml) enhanced TLR3 and p-IRF3 protein expressions, and promoted ,IFN⁃β, mRNA expression in cell(,P<,0.01). After Bushen Jianpi Decoction intervened in HepG2 cells transfected with plasmid pHBV1.3-pCR2.1, TLR3 siRNA inhibited TLR3 protein expression and p-IRF3 protein expression was decreased significantly and the expression of intracellular ,IFN⁃β ,mRNA expression was decreased significantly.,Conclusion,2,The water extract of Bushen Jianpi Decoction can inhibit hepatitis B virus replication by enhancement of TLR3 effect in HepG2 cells transfected with plasmid pHBV1.3-pCR2.1 and promotion of intracellular IFN-β secretion.
补肾健脾方水提物乙型肝炎病毒Toll样受体3
water extract of Bushen Jianpi Recipehepatitis B virusToll-like receptor 3
王贵强,王福生,庄辉,等. 慢性乙型肝炎防治指南(2019年版)[J].中国医学前沿杂志(电子版),2019, 11(12): 51-77.
孙学华,朱晓骏,高月求,等.灵猫方联合恩替卡韦治疗慢性乙型肝炎临床研究[J].上海中医药大学学报,2012, 26(6): 42-44.
ZHU X J,SUN X H,ZHOU Z H,et al.Lingmao Formula Combined with Entecavir for HBeAg-Positive Chronic Hepatitis B Patients with Mildly Elevated Alanine Aminotransferase:A Multicenter,Randomized,Double-Blind,Placebo-Controlled Trial[J/OL].Evid Based Complement Alternat Med,2013, 2013: 620230.
朱晓骏,张鑫,周振华,等. 灵猫方通过增强天然免疫功能抑制乙型肝炎病毒复制的研究[J]. 中国中西医结合肝病杂志,2018, 28(1): 33-36.
赵钢,陈建杰. 王灵台教授论补肾法为主治疗慢性乙型肝炎的机制[J]. 中国中西医结合杂志,2005, 25(1): 78-79.
DAWOOD A,ABDUL BASIT S,JAYARAJ M,et al. Drugs in Development for hepatitis B[J]. Drugs,2017, 77(12): 1263-1280.
LUCIFORA J,BONNIN M,AILLOT L,et al. Direct antiviral properties of TLR ligands against HBV replication in immune-competent hepatocytes[J]. Sci Rep,2018, 8(1):5390.
陈丽萍,黄俊,程计林. Toll样受体介导的固有免疫应答在HBV感染中的研究进展[J],中华微生物学和免疫学杂志,2018, 38(8): 635-640.
李冰,龚国忠. Toll 样受体3及其在乙型病毒性肝炎中的作用[J]. 长治医学院学报,2010, 24(5): 397-400.
HUANG Y W,LIN S C,WEI S C,et al. Reduced Toll-like receptor 3 experssion in chronic hepatitis B patients and its restoration by interferon therapy[J]. Antivir Ther, 2013, 18(7): 877-884.
LUANGSAY S,AIT-GOUGHOULTE M,MICHELET M,et al. Expression and functionality of Toll- and RIG-like receptors in HepaRG cells[J]. J Hepatol, 2015, 63(5): 1077-1085.
WU J,HUANG S M,ZHAO X L, et al. Poly(I:C)treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model[J]. J Virol,2014,88(18):10421-10431.
ISOGAWA M,ROBEK M D,FURUICHI Y,et al. Toll-like receptor signaling inhibits hepatitis B virus replication in vivo[J]. J Virol, 2005, 79(11): 7269-7272.
0
浏览量
110
下载量
0
CSCD
0
CNKI被引量
关联资源
相关文章
相关作者
相关机构